Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing
Open Access
- 15 December 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 20 (1), 75-79
- https://doi.org/10.1038/nm.3412
Abstract
Understanding how Mycobacterium tuberculosis is controlled by the body, leading to active disease in only a small fraction of infected individuals, is important for developing medical interventions to prevent and manage disease. Lin et al. now show that infected macaques with active tuberculosis have some sterile granulomas, suggesting immune-mediated control at certain sites of infection. Insight into the mechanisms underlying the heterogeneity of mycobacterial killing may inform vaccine development. Over 30% of the world's population is infected with Mycobacterium tuberculosis (Mtb), yet only ∼5–10% will develop clinical disease1. Despite considerable effort, researchers understand little about what distinguishes individuals whose infection progresses to active tuberculosis (TB) from those whose infection remains latent for decades. The variable course of disease is recapitulated in cynomolgus macaques infected with Mtb2. Active disease occurs in ∼45% of infected macaques and is defined by clinical, microbiologic and immunologic signs, whereas the remaining infected animals are clinically asymptomatic2,3. Here, we use individually marked Mtb isolates and quantitative measures of culturable and cumulative bacterial burden to show that most lung lesions are probably founded by a single bacterium and reach similar maximum burdens. Despite this observation, the fate of individual lesions varies substantially within the same host. Notably, in active disease, the host sterilizes some lesions even while others progress. Our data suggest that lesional heterogeneity arises, in part, through differential killing of bacteria after the onset of adaptive immunity. Thus, individual lesions follow diverse and overlapping trajectories, suggesting that critical responses occur at a lesional level to ultimately determine the clinical outcome of infection. Defining the local factors that dictate outcome will be useful in developing effective interventions to prevent active TB.Keywords
This publication has 20 references indexed in Scilit:
- TuberculosisThe New England Journal of Medicine, 2013
- Infection Dynamics and Response to Chemotherapy in a Rabbit Model of Tuberculosis using [ 18 F]2-Fluoro-Deoxy- d -Glucose Positron Emission Tomography and Computed TomographyAntimicrobial Agents and Chemotherapy, 2012
- Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaquesProceedings of the National Academy of Sciences of the United States of America, 2012
- Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infectionNature Genetics, 2011
- Understanding Latent Tuberculosis: A Moving TargetThe Journal of Immunology, 2010
- Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque modelArthritis & Rheumatism, 2010
- Quantitative Comparison of Active and Latent Tuberculosis in the Cynomolgus Macaque ModelInfection and Immunity, 2009
- The Role of the Granuloma in Expansion and Dissemination of Early Tuberculous InfectionCell, 2009
- Early Events in Mycobacterium tuberculosis Infection in Cynomolgus MacaquesInfection and Immunity, 2006
- THE TREATED PULMONARY LESION AND ITS TUBERCLE BACILLUS.*The American Journal of the Medical Sciences, 1956